RxDoctor Payments Data

Aimee Tegtmeier, DO

Family Medicine · Lansing, MINPI 1497042972

Payments from drug & device makers

$650in general payments, 2019–2025

Across 42 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prugen, Inc. Pharmaceuticals$129
  • Novo Nordisk$66
  • AstraZeneca$58
  • GSK$55
  • Merck$46
  • Pfizer$44
  • plus $252 from 11 others

What the payments were for

  • Food & beverage$650100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$650 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$13,174
Medicare patients
65
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide45$57,090
OzempicSemaglutide47$53,710
ProliaDenosumab26$42,902
EliquisApixaban28$36,474
JanuviaSitagliptin Phosphate22$33,571
XareltoRivaroxaban24$28,238
JardianceEmpagliflozin21$22,456
MyrbetriqMirabegron19$17,091
FarxigaDapagliflozin Propanediol12$14,661
LinzessLinaclotide14$8,847
Bydureon BciseExenatide Microspheres11$8,621
TrintellixVortioxetine Hydrobromide11$5,182
Bupropion XlBupropion Hcl49$3,726
Levothyroxine Sodium266$3,709
Rosuvastatin Calcium105$3,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$66$53,71047 claims
AmgenProlia$15$42,90226 claims
PfizerEliquis$44$36,47428 claims
MerckJanuvia$46$33,57122 claims
Johnson & JohnsonXarelto$16$28,23824 claims
Boehringer IngelheimJardiance$16$22,45621 claims
AstraZenecaFarxiga$58$14,66112 claims
AbbVieLinzess, Armour Thyroid$29$10,76335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →